siRNA targeting stathmin inhibits invasion and enhances chemotherapy sensitivity of stem cells derived from glioma cell lines

Clinical significance of vasculogenic mimicry in human gliomas

(2011) Xiao-mei Liu et al.   JOURNAL OF NEURO-ONCOLOGY

Demonstration of vasculogenic mimicry in astrocytomas and effects of Endostar on U251 cells

(2011) Zhengcao Liu et al.   PATHOLOGY RESEARCH AND PRACTICE

Concise Review: Contribution of Cancer Stem Cells to Neovascularization

(2011) Yi-Fang Ping et al.   STEM CELLS

A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry

(2010) S. El Hallani et al.   BRAIN

Cancer Stem Cells and Self-renewal

(2010) C. A. O'Brien et al.   CLINICAL CANCER RESEARCH

Glioma stem cell signaling: therapeutic opportunities and challenges

(2010) Jörg Dietrich et al.   Expert Review of Anticancer Therapy

Survival comparison between glioblastoma multiforme and other incurable cancers

(2010) B. Tran et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Vasculogenic mimicry–potential target for glioblastoma therapy: an in vitro and in vivo study

(2010) Yinsheng Chen et al.   MEDICAL ONCOLOGY

EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphology

(2008) SEBASTIAN LEIBL et al.   APMIS

Stathmin 1: a novel therapeutic target for anticancer activity

(2008) Shushan Rana et al.   Expert Review of Anticancer Therapy

Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors

(2008) Baocun Sun et al.   HUMAN PATHOLOGY